Summit Therapeutics Inc. Common Stock (SMMT)
SMMT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$15.52
-9.40% on the day
Market cap
$12.4B
Large cap
Revenue · 2024
$0
Prior year not contiguous
Net income · 2024
-$221.3M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | SMMT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001599298 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DELAWARE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$221.3M |
| Operating income | -$226.0M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $104.9M |
| Total assets | $435.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-23 |
| Latest annual report | 10-K | 2026-02-23 |
| Latest quarterly / interim | 10-Q | 2026-07-23 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | PRE 14A | 2026-10-06 |
Source: SEC EDGAR submissions feed, 556 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -15.7% |
| 1 month | -13.0% |
| 3 months | +10.0% |
| Year to date | -13.4% |
| 1 year | -34.0% |
| From 52-week high | -42.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. | $63.30 | -3.73% | $12.4B |
| CORT | Corcept Therapeutics Incorporated | $117.80 | -2.80% | $12.7B |
| JAZZ | Jazz Pharmaceuticals plc Common Stock (Ireland) | $210.39 | -2.93% | $13.7B |
| ELAN | Elanco Animal Health Incorporated | $22.41 | -0.67% | $11.2B |
| RDY | Dr. Reddy's Laboratories Ltd | $12.77 | -0.39% | $10.7B |
| BMRN | BioMarin Pharmaceutical Inc. | $54.38 | -1.82% | $10.5B |
| ASND | Ascendis Pharma A/S Ordinary Share | $223.21 | -1.67% | $14.7B |
| MDGL | Madrigal Pharmaceuticals Inc. | $452.12 | -3.22% | $10.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier